Alamar Biosciences, Inc. (ALMR) Financial Statements

12 Followers

Alamar Biosciences, Inc. Financial Overview

Alamar Biosciences, Inc.'s market cap is currently $1.52B. The company's EPS TTM is $-0.31; its P/E ratio is -48.99; Alamar Biosciences, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25
Income Statement
Total Revenue	$ 74.21M
Gross Profit	$ 41.70M
Operating Income	$ -31.33M
EBITDA	$ -24.89M
Net Income	$ -29.82M
Balance Sheet
Cash & Short-Term Investments	$ 30.00M
Total Assets	$ 139.99M
Total Debt	$ 41.47M
Net Debt	$ 11.47M
Total Liabilities	$ 298.95M
Stockholders' Equity	$ -158.95M
Cash Flow
Free Cash Flow	$ -59.99M
Operating Cash Flow	$ -53.61M
Investing Cash Flow	$ 46.18M
Financing Cash Flow	$ 10.84M

Currency in USD

Alamar Biosciences, Inc. Earnings and Revenue History

Income Statement >

Alamar Biosciences, Inc. Debt to Assets

Balance Sheet >

Alamar Biosciences, Inc. Cash Flow

Cash Flow >

Alamar Biosciences, Inc. Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >